Clinical trials for Chronic bilirubin encephalopathy
28 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 3NCT07342478ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLLNewave Pharmaceutical Inc
- RECRUITINGPhase 2NCT07530445Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract CancerSun Yat-sen University
- RECRUITINGPHASE1, PHASE2NCT07281976A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast CancerNanjing Leads Biolabs Co.,Ltd · PI: yongmei Yin
- RECRUITINGPhase 2NCT07537660Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus PaclitaxelSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT03537794Characterizing Dopamine Receptor Binding in Treatment Resistant DepressionUnity Health Toronto · PI: Sakina J Rizvi, PhD
- RECRUITINGPhase 1NCT07096869Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer PatientsCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- RECRUITINGPhase 2NCT06947291Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid TumorsCSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- RECRUITINGN/ANCT06765590Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast CancerSichuan Huiyu Pharmaceutical Co., Ltd
- RECRUITINGN/ANCT06856200A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerFudan University
- RECRUITINGPhase 2NCT06587061HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic CancerRuijin Hospital
- RECRUITINGPhase 2NCT06252571a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -TrialUniversity Hospital, Strasbourg, France
- RECRUITINGPhase 2NCT06467617Adebrelimab Plus Chemo and Recaticimab in Perioperative Treatment of Resectable NSCLCBeijing Chest Hospital, Capital Medical University · PI: Jinghui Wang
- RECRUITINGEarly Phase 1NCT06562361A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.Antaros Medical · PI: Johan Vessby
- RECRUITINGNCT07434908Heparin-binding Protein and Lungedema in ICU Patients.Umeå University
- RECRUITINGPhase 2NCT06316960Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT MutationChildren's Hospital of Soochow University · PI: Shaoyan Hu, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT06957379Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard TherapyCSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- RECRUITINGNCT06252493Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.Massachusetts General Hospital · PI: Onofrio Catalano, MD, Ph.D
- RECRUITINGPhase 2NCT059807024 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCCSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- ACTIVE NOT RECRUITINGPhase 1NCT05528848Multi-System Analysis of Opioid Receptor BindingUniversity of Pennsylvania
- RECRUITINGPhase 1NCT05452005Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerUniversity of California, Davis · PI: Julie L. Sutcliffe, PhD
- RECRUITINGPhase 3NCT04137653Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCTShengjing Hospital · PI: Caigang Liu, M.D., Ph.D.
- RECRUITINGN/ANCT05926219C-Protein in Fatigue and AgingUniversity of Oregon · PI: Damien M Callahan, Ph.D.
- ACTIVE NOT RECRUITINGPhase 2NCT02788981Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast CancerUniversity of Chicago · PI: Rita Nanda, M.D.
- ACTIVE NOT RECRUITINGEarly Phase 1NCT03164486First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-PeptideJulie L. Sutcliffe, Ph.D · PI: Julie Sutcliffe
- RECRUITINGNCT05169541Association Between Plasma Level of Mannose Binding Lectin and Human ReproductionAalborg University Hospital · PI: Caroline Nørgaard-Pedersen, M.D.
- ACTIVE NOT RECRUITINGNCT02650843Non-motor Symptoms and Brain Dopamine Transporter BindingTurku University Hospital
- ACTIVE NOT RECRUITINGNCT02258035Isolation of Vitamin D Binding Protein Isoforms From Human VolunteersUniversitaire Ziekenhuizen KU Leuven · PI: Dirk Vanderschueren, MD PhD
- RECRUITINGNCT02253251Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and TreatmentMiraKind · PI: Joanne Weidhaas, MDPhD